Compound Detail

CHEMBL318368

Enter ChEMBL ID:

Free Research Context This compound will appear in recent viewed items on the research home for this browser.

CC(=O)OC1C(=O)C2(C)C(O)CC3OCC3(OC(C)=O)C2C(OC(=O)C2CCCCC2)C2(O)CC(OC(=O)C(O)C(C=C(C)C)NC(=O)OC(C)(C)C)C(C)=C1C2(C)C

ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID	CHEMBL318368
Phase	Preclinical
Structure Type	MOL
InChI Key	NQTKKGXCIFPLDD-UHFFFAOYSA-N

Targets

Activities

Assay Types

PK Parameters

Publications

Known Names

834.0

MW (Da)

3.69

ALogP

HBA

HBD

230.5

PSA (Å²)

0.15

QED

Ro5 Violations

Rot. Bonds

First in Class Prodrug

IC50 5 meas. best 9.3

Target	Type	Best pChEMBL	Mean pChEMBL	Best (nM)	# Data
MCF7 CHEMBL387	IC50	9.3	9.3	0.5	1
A549 CHEMBL392	IC50	8.89	8.89	1.3	1
A121 CHEMBL613106	IC50	8.82	8.82	1.5	1
HT-29 CHEMBL384	IC50	8.77	8.77	1.7	1
MCF7R CHEMBL614327	IC50	7.58	7.58	26.0	1

Top measurements by pChEMBL value

Target	Type	Rel.	Value	Units	pChEMBL	Assay	PubMed
MCF7	IC50	=	0.5	nM	9.3	Inhibition of the growth against human mammary carcinoma (MCF-7) cell line after...	9022794
A549	IC50	=	1.3	nM	8.89	Inhibition of the growth against human non-small-lung carcinoma (A549) cell line...	9022794
A121	IC50	=	1.5	nM	8.82	Inhibition of the growth against human Ovarian Carcinoma (A121) cell line after ...	9022794
HT-29	IC50	=	1.7	nM	8.77	Inhibition of the growth against human Colon Carcinoma (HT-29) cell line after 7...	9022794
MCF7R	IC50	=	26.0	nM	7.58	Inhibition of the growth against human mammary carcinoma 180 fold resistant to d...	9022794

PubMed	DOI	Target Context	# Activities
9022794	10.1021/jm9606711	A121	1
9022794	10.1021/jm9606711	A549	1
9022794	10.1021/jm9606711	HT-29	1
9022794	10.1021/jm9606711	MCF7	1
9022794	10.1021/jm9606711	MCF7R	1

Data from ChEMBL 36 via Core Engine